Fibrinolysis Greater Than 3% is the Critical Value for Initiation of Antifibrinolytic Therapy

Overview

Journal J Trauma Acute Care Surg

Specialty Critical Care

Date 2013 Nov 22

PMID 24256667

Citations 71

Authors

Michael P Chapman

Ernest E Moore

Christopher R Ramos

Arsen Ghasabyan

Jeffrey N Harr

Theresa L Chin

John R Stringham

Angela Sauaia

Christopher C Silliman

Anirban Banerjee

Affiliations

Soon will be listed here.

Abstract

Background: The acute coagulopathy of trauma is present in up to one third of patients by the time of admission, and the recent CRASH-2 and MATTERs trials have focused worldwide attention on hyperfibrinolysis as a component of acute coagulopathy of trauma. Thromboelastography (TEG) is a powerful tool for analyzing fibrinolyis, but a clinically relevant threshold for defining hyperfibrinolysis has yet to be determined. Recent data suggest that the accepted normal upper bound of 7.5% for 30-minute fibrinolysis (LY30) by TEG is inappropriate in severe trauma, as the risk of death rises at much lower levels of clot lysis. We wished to determine the validity of this hypothesis and establish a threshold value to treat fibrinolysis, based on prediction of massive transfusion requirement and risk of mortality.

Methods: Patients with uncontrolled hemorrhage, meeting the massive transfusion protocol (MTP) criteria at admission (n = 73), represent the most severely injured trauma population at our center (median Injury Severity Score [ISS], 30; interquartile range, 20-38). Citrated kaolin TEG was performed at admission blood samples from this population, stratified by LY30, and evaluated for transfusion requirement and 28-day mortality. The same analysis was conducted on available field blood samples from all non-MTP trauma patients (n = 216) in the same period. These represent the general trauma population.

Results: Within the MTP-activating population, the cohort of patients with LY30 of 3% or greater was shown to be at much higher risk for requiring a massive transfusion (90.9% vs. 30.5%, p = 0.0008) and dying of hemorrhage (45.5% vs. 4.8%, p = 0.0014) than those with LY30 less than 3%. Similar trends were seen in the general trauma population.

Conclusion: LY30 of 3% or greater defines clinically relevant hyperfibrinolysis and strongly predicts the requirement for massive transfusion and an increased risk of mortality in trauma patients presenting with uncontrolled hemorrhage. This threshold value for LY30 represents a critical indication for the treatment of fibrinolysis.

Level Of Evidence: Prognostic study, level III.

Citing Articles

Measurement of Blood Viscoelasticity Using Thromboelastography.

Volod O, Runge A Methods Mol Biol. 2023; 2663:709-724.

PMID: 37204747 DOI: 10.1007/978-1-0716-3175-1_47.

The first case of hyperfibrinolysis induced by delayed hemolytic transfusion reaction in a trauma patient.

Lim H, Jang H Blood Transfus. 2023; 22(1):34-36.

PMID: 37146301 PMC: 10812894. DOI: 10.2450/BloodTransfus.507.

Hemorrhagic shock and tissue injury provoke distinct components of trauma-induced coagulopathy in a swine model.

Cralley A, Moore E, Coleman J, Vigneshwar N, Bartley M, Kissau D Eur J Trauma Emerg Surg. 2022; 49(2):1079-1089.

PMID: 36319860 PMC: 10802987. DOI: 10.1007/s00068-022-02148-x.

Fibrinolysis in Dogs with Intracavitary Effusion: A Review.

Zoia A, Drigo M, Caldin M, Simioni P, Piek C Animals (Basel). 2022; 12(19).

PMID: 36230236 PMC: 9558497. DOI: 10.3390/ani12192487.

Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion.

Moore H, Neal M, Bertolet M, Joughin B, Yaffe M, Barrett C Ann Surg Open. 2022; 3(2).

PMID: 36177090 PMC: 9514137. DOI: 10.1097/as9.0000000000000167.

References

Mitra B, Rainer T, Cameron P . Predicting massive blood transfusion using clinical scores post-trauma. Vox Sang. 2011; 102(4):324-30. DOI: 10.1111/j.1423-0410.2011.01564.x. View

Neal M, Marsh A, Marino R, Kautza B, Raval J, Forsythe R . Massive transfusion: an evidence-based review of recent developments. Arch Surg. 2012; 147(6):563-71. DOI: 10.1001/archsurg.2011.2212. View

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y . The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096-101, 1101.e1-2. DOI: 10.1016/S0140-6736(11)60278-X. View

Ganter M, Pittet J . New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol. 2010; 24(1):15-25. DOI: 10.1016/j.bpa.2009.09.010. View

Morton A, Moore E, Wohlauer M, Lo K, Silliman C, Burlew C . Revisiting early postinjury mortality: are they bleeding because they are dying or dying because they are bleeding?. J Surg Res. 2012; 179(1):5-9. PMC: 4203315. DOI: 10.1016/j.jss.2012.05.054. View

Morrison J, Dubose J, Rasmussen T, Midwinter M . Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2011; 147(2):113-9. DOI: 10.1001/archsurg.2011.287. View

Brohi K, Cohen M, Ganter M, Matthay M, Mackersie R, Pittet J . Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg. 2007; 245(5):812-8. PMC: 1877079. DOI: 10.1097/01.sla.0000256862.79374.31. View

Kashuk J, Moore E, Sawyer M, Wohlauer M, Pezold M, Barnett C . Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010; 252(3):434-42. DOI: 10.1097/SLA.0b013e3181f09191. View

Gonzalez E, Moore F, Holcomb J, Miller C, Kozar R, Todd S . Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma. 2007; 62(1):112-9. DOI: 10.1097/01.ta.0000250497.08101.8b. View

10.

Mitra B, Cameron P, Gruen R, Mori A, Fitzgerald M, Street A . The definition of massive transfusion in trauma: a critical variable in examining evidence for resuscitation. Eur J Emerg Med. 2010; 18(3):137-42. DOI: 10.1097/MEJ.0b013e328342310e. View

11.

Brohi K, Cohen M, Ganter M, Schultz M, Levi M, Mackersie R . Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008; 64(5):1211-7. DOI: 10.1097/TA.0b013e318169cd3c. View

12.

Brown J, Cohen M, Minei J, Maier R, West M, Billiar T . Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg. 2012; 73(2):358-64. DOI: 10.1097/TA.0b013e31825889ba. View

13.

Kashuk J, Moore E, Johnson J, Haenel J, Wilson M, Moore J . Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?. J Trauma. 2008; 65(2):261-70. DOI: 10.1097/TA.0b013e31817de3e1. View

14.

Neal M, Hoffman M, Cuschieri J, Minei J, Maier R, Harbrecht B . Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way. J Trauma Acute Care Surg. 2012; 72(4):892-8. PMC: 3347772. DOI: 10.1097/TA.0b013e31823d84a7. View

15.

Sperry J, Ochoa J, Gunn S, Alarcon L, Minei J, Cuschieri J . An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008; 65(5):986-93. DOI: 10.1097/TA.0b013e3181878028. View

16.

Kashuk J, Moore E, Sawyer M, Le T, Johnson J, Biffl W . Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010; 251(4):604-14. DOI: 10.1097/SLA.0b013e3181d3599c. View

17.

Schochl H, Maegele M, Solomon C, Gorlinger K, Voelckel W . Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012; 20:15. PMC: 3306198. DOI: 10.1186/1757-7241-20-15. View

18.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

19.

Brohi K, Cohen M, Davenport R . Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007; 13(6):680-5. DOI: 10.1097/MCC.0b013e3282f1e78f. View

20.

Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt B . Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012; 345:e5839. PMC: 3439642. DOI: 10.1136/bmj.e5839. View